These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21058912)

  • 1. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.
    Bausch DG; Hadi CM; Khan SH; Lertora JJ
    Clin Infect Dis; 2010 Dec; 51(12):1435-41. PubMed ID: 21058912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin for Lassa fever postexposure prophylaxis.
    Hadi CM; Goba A; Khan SH; Bangura J; Sankoh M; Koroma S; Juana B; Bah A; Coulibaly M; Bausch DG
    Emerg Infect Dis; 2010 Dec; 16(12):2009-11. PubMed ID: 21122249
    [No Abstract]   [Full Text] [Related]  

  • 3. Lassa fever. Effective therapy with ribavirin.
    McCormick JB; King IJ; Webb PA; Scribner CL; Craven RB; Johnson KM; Elliott LH; Belmont-Williams R
    N Engl J Med; 1986 Jan; 314(1):20-6. PubMed ID: 3940312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imported Lassa fever in Germany: surveillance and management of contact persons.
    Haas WH; Breuer T; Pfaff G; Schmitz H; Köhler P; Asper M; Emmerich P; Drosten C; Gölnitz U; Fleischer K; Günther S
    Clin Infect Dis; 2003 May; 36(10):1254-8. PubMed ID: 12746770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to reconsider the role of ribavirin in Lassa fever.
    Salam AP; Cheng V; Edwards T; Olliaro P; Sterne J; Horby P
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009522. PubMed ID: 34237063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L; Rieger T; Lüdtke A; Ruibal P; Wurr S; Pallasch E; Bockholt S; Krasemann S; Muñoz-Fontela C; Günther S
    J Infect Dis; 2016 Mar; 213(6):934-8. PubMed ID: 26531247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections.
    Okogbenin S; Erameh C; Okoeguale J; Edeawe O; Ekuaze E; Iraoyah K; Agho J; Groger M; Kreuels B; Oestereich L; Babatunde FO; Akhideno P; Günther S; Ramharter M; Omansen T
    Emerg Infect Dis; 2022 Oct; 28(10):2060-2063. PubMed ID: 36148915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria.
    Groger M; Akhideno P; Kleist CJ; Babatunde FO; Edeawe O; Hinzmann J; Akhigbe T; Nwatuzor J; Eifediyi G; Müller J; Hinrichs M; Pahlmann M; Sarpong FN; Wagner C; Thielebein A; Aihonwalan L; Koch T; Riedner M; Ogbaini-Emovon E; Okogbenin S; Günther S; Wicha SG; Ramharter M; Oestereich L; Duraffour S; Erameh C
    Clin Infect Dis; 2023 Feb; 76(3):e841-e848. PubMed ID: 35881530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imported Lassa fever: a report of 2 cases in Ghana.
    Kyei NN; Abilba MM; Kwawu FK; Agbenohevi PG; Bonney JH; Agbemaple TK; Nimo-Paintsil SC; Ampofo W; Ohene SA; Nyarko EO
    BMC Infect Dis; 2015 May; 15():217. PubMed ID: 26022703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
    Cheng HY; French CE; Salam AP; Dawson S; McAleenan A; McGuinness LA; Savović J; Horby PW; Sterne JAC
    Emerg Infect Dis; 2022 Aug; 28(8):1559-1568. PubMed ID: 35876478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
    Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
    Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lassa fever presenting as acute abdomen: a case series.
    Dongo AE; Kesieme EB; Iyamu CE; Okokhere PO; Akhuemokhan OC; Akpede GO
    Virol J; 2013 Apr; 10():123. PubMed ID: 23597024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases.
    Wolf T; Ellwanger R; Goetsch U; Wetzstein N; Gottschalk R
    J Travel Med; 2020 Jul; 27(4):. PubMed ID: 32219400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Favipiravir to Treat Lassa Virus Infection in Macaques.
    Rosenke K; Feldmann H; Westover JB; Hanley PW; Martellaro C; Feldmann F; Saturday G; Lovaglio J; Scott DP; Furuta Y; Komeno T; Gowen BB; Safronetz D
    Emerg Infect Dis; 2018 Sep; 24(9):1696-1699. PubMed ID: 29882740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.
    Salam AP; Duvignaud A; Jaspard M; Malvy D; Carroll M; Tarning J; Olliaro PL; Horby PW
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010289. PubMed ID: 35353804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and patient management of Lujo hemorrhagic fever.
    Sewlall NH; Richards G; Duse A; Swanepoel R; Paweska J; Blumberg L; Dinh TH; Bausch D
    PLoS Negl Trop Dis; 2014; 8(11):e3233. PubMed ID: 25393244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining Ribavirin's mechanism of action against Lassa virus infection.
    Carrillo-Bustamante P; Nguyen THT; Oestereich L; Günther S; Guedj J; Graw F
    Sci Rep; 2017 Sep; 7(1):11693. PubMed ID: 28916737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis.
    Eberhardt KA; Mischlinger J; Jordan S; Groger M; Günther S; Ramharter M
    Int J Infect Dis; 2019 Oct; 87():15-20. PubMed ID: 31357056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S; Eickmann M; Strecker T; Brown S; Patel K; De Leuw P; Schuettfort G; Stephan C; Rabenau H; Klena JD; Rollin PE; McElroy A; Ströher U; Nichol S; Kraft CS; Wolf T;
    Clin Infect Dis; 2017 Sep; 65(5):855-859. PubMed ID: 29017278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.